Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

By S. Vaccarella, Silvia Franceschi, F. Bray, C. Wild, Martyn Plummer, L. Dal Maso. New England Journal of Medicine, 2016

1,027 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Oncology, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/2df4a9e11d016a6d5dd7ca32b4efb22db8613de6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. A. Jemal
2. R. Siegel

In Oncology

1. A. Jemal
2. R. Siegel
3. F. Bray
4. J. Ferlay
5. Isabelle Soerjomataram
6. M. Laversanne
7. M. Colombet
8. D. M. Parkin

In Statistics and Probability

1. F. Bray
2. A. Jemal
3. R. Siegel

Citations in the corpus

• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 (2018, neutral): “Mesothelioma 35 (33-36) 24 (22-26) 10 (10-11) 0.”
• Cancer statistics for the year 2020: An overview (2021, background): “Conversely, there is the prospect of an inflation of incidence rates for certain cancers where there may have been extensive screening for asymptomatic disease, or an increased amount of accidental findings emerging from the use of high-resolution imaging techniques; this refers to cancers of the pr”
• The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide (2024, neutral): “16 The estimation of new cases of non-melanoma skin cancer poses specific difficulties given variations in diagnostic and registration practice in different countries and world regions, leading to variations in the completeness and accuracy of the incidence burden of non-melanoma skin cancer as…”
• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2019, background): “Molecular profiling has distinguished two major classes of PTCs characterised by BRAF-predominant and RAS-predominant molecular signatures (Table 1) [19].”
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2024, background): “147,148 In a study of 25 countries, the increases were mainly confined to papillary carcinomas commonly detected by intense scrutiny of the thyroid gland.”